References
- Bouloukaki I, Mermigkis C, Kallergis EM, et al. Obstructive sleep apnea syndrome and cardiovascular disease: the influence of C-reactive protein. World J Exp Med 2015;5:77-83
- Lindberg E, Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000;4:411-33
- Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39
- Stradling JR, Davies RJ. Sleep 1: obstructive sleep apnea/hypopnea syndrome: definitions, epidemiology, and natural history. Thorax 2004;59:73-8
- Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5
- Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H, et al. Serum inflammatory markers in obstructive sleep apnea: a metaanalysis. J Clin Sleep Med 2013;9:1003-12
- Kılıç O, Bayram H (ed.). Türk Toraks Derneği Obstrüktif Uyku Apne Sendromu Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2012;13:1-33.16
- Kostakis ID, Cholidou KG, Kallianidis K, et al. The role of calprotectin in obstetrics and gynecology. Eur J Obstet Gynecol Reprod Biol 2010;151:3-9
- Croce K. S100A8/A9 complex: more than just a biomarker of cardiovascular risk? Circ J 2010;74:626-7
- Ehrchen JM, Sunderkötter C, Foell D, et al. The endogenous Toll like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009;86:557-66
- Ichikawa, M, Williams R, Wang L, et al. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 2011;9:133-48
- Kallberg E, Vogl T, Liberg D, et al. S100A9 interaction with TLR4 promotes tumor growth. PLoS One 2012;7:e34207
- Berthier S, Nguyen MV, Baillet A, et al. Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation. PLoS One 2012;7:e40277
- Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer 2015;15:96-109
- Hurnakova J, Zavada J, Hanova P, et al. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Res Ther 2015;17:252
- Decembrino L, De Amici M, Pozzi M, et al. Serum calprotectin: a potential biomarker for neonatal sepsis. J Immunol Res 2015;2015:147973. doi: 10.1155/2015/147973. Epub 2015 Aug 26
- Oktayoglu P, Mete N, Caglayan M, et al. Elevated serum levels of calprotectin (MRP8/MRP14) in patients with Behçet’s disease and its association with disease activity and quality of life. Scand J Clin Lab Invest 2015;75:106-12
- Carroccio A, Rocco P, Rabitti PG, et al. Plasma calprotectin levels in patients suffering from acute pancreatitis. Dig Dis Sci 2006;51:1749-53
- Cholidou KG, Kostakis ID, Manali ED, et al. Calprotectin: a protein related to cardiovascular risk in adult patients with obstructive sleep apnea. Cytokine 2013;61:917-23
- Kim J, Bhattacharjee R, Snow AB, et al. Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea. Eur Respir J 2010;35:843-50
- Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009;5:263-76
- Aihara K, Oga T, Chihara Y, et al. Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath 2013;17:597-604
- Panoutsopoulos A, Kallianos A, Kostopoulos K, et al. Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea. Med Sci Monit 2012;18:CR747-51
- Kwan SYL, Fleetham JA, Enarson DA, Chan-Yeung M. Snoring, obesity, smoking and systemic hypertension in a working population in British Columbia. Am Rev Respir Dis 1991;143:A380
- Schwab RJ, Goldberg AN, Pack AL. Sleep apnea syndromes. In: Fishman AP (ed). Fishman’ s Pulmonary Diseases and Disorders. New York: McGraw-Hill Book Company, 1998:1617-37
- Guilleminault C, Partinen M, Hollman K, et al. Familial aggregates in obstructive sleep apnea syndrome. Chest 1995;107;1545-51
- Shi YK, Chen JX, Huang Y, Li AY. Serum S100A12 levels are associated with the presence and severity of obstructive sleep apnea syndrome in male patients. Sleep Breath 2014;18:269-74
- Minoguchi K, Tazaki T, Yokoe T, et al. Elevated production of tumor necrosis factor-alpha by monocytes inpatients with obstructive sleep apnea syndrome. Chest 2004;126:1473-9
- Steiropoulos P, Papanas N, Nena E, et al. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators Inflamm 2010;2010:675320. doi: 10.1155/2010/675320. Epub 2010 Jun 8
- Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of c-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-34
- Yardim-Akaydin S, Caliskan-Can E, Firat H, et al. Influence of gender on C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in obstructive sleep apnea. Antiinflamm Antiallergy Agents Med Chem 2014;13:56-63
- Min JY, Jang JY, Kim HY, et al. A relationship between the obstructive sleep apnea syndrome and the erythrocyte sedimentation rate. Clin Exp Otorhinolaryngol 2009;2:126-30
- Korkmaz M, Korkmaz H, Küçüker F, et al. Evaluation of the association of sleep apnea-related systemic inflammation with CRP, ESR, and neutrophil-to-lymphocyte ratio. Med Sci Monit 2015;21:477-81